Format

Send to

Choose Destination
See comment in PubMed Commons below

99mTc-1,4,7-Tris(carboxymethyl)-10-(4-aminoethyl)-1,4,7,10-tetraazacyclododecane-Folate.

Authors

Leung K.

Source

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2012 Nov 22 [updated 2013 Jan 31].

Excerpt

Folic acid is a water-soluble B vitamin (1). It is essential for methylation and DNA synthesis. The primary pathway for entry of folate into cells is through a facilitated transporter, which has a low affinity for folate (Km, 1–5 μM). Some cells in the choroid plexus, kidney, lung, thyroid, spleen, placenta, and thymus also possess a receptor with higher affinity (Kd, 0.5 nM), which allows folate uptake via receptor-mediated endocytosis. Some human epithelial tumor cells were found to overexpress folate receptors (2). More than 90% of human ovarian and endometrial cancers express the high-affinity receptor, which is absent in the normal tissues. Breast, colorectal, renal, and lung carcinomas also overexpressed the high-affinity folate receptor but to a lesser frequency (20%–50%). Several 99mTc-based folate conjugates have been developed for single-photon emission computed tomography (SPECT) imaging of folate receptor expression in tumors such as 99mTc-ethylenedicysteine-folate, 99mTc-HYNIC-Folate, and 99mTc-DTPA-Folate (3). Mishra et al. (4) prepared 99mTc-1,4,7-tris(carboxymethyl)-10-(4-aminoethyl)-1,4,7,10-tetraazacyclododecane-folate (99mTc-DO3A-EA-Folate) as a new 99mTc-based folate conjugate for SPECT imaging studies.

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons
    Support Center